Prof. Dr. med. Dr. h.c. Peter Paul Nawroth has joined our Scientific Advisory Board.
top of page
    • Apr 1, 2017

Prof. Dr. med. Dr. h.c. Peter Paul Nawroth has joined our Scientific Advisory Board.

We are proud to announce that Prof. Dr. med. Dr. h.c. Peter Paul Nawroth

has joined our Scientific Advisory Board.


Prof. Dr. med. Dr. h.c. Peter Paul Nawroth
Prof. Dr. med. Dr. h.c. Peter Paul Nawroth

Among his many achievements, Prof. Nawroth is the awardee of the 2018 Camillo Golgi Prize - a Prize for outstanding ontributions in the field of the histopathology, pathogenesis, prevention and treatment of the complications of diabetes mellitus. Prof. Nawroth was awarded the prize for his work on "Diabetic complications: an alternative view on diabetes"the Long School of Medicine at University of Texas Health San Antonio, where he has been on faculty since 1988.






Logo concenter biopharma.jpg

Hi, thanks for stopping by!

Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., which developed a novel, protected PLATFORM of drugs for proven treatments of multiple indications. 

 

Our PLATFORM is the result of extensive investigation of animal models of human diseases.

Let the news
come to you.

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
bottom of page